Medical management in locally advanced and metastatic prostate cancer: Does changes in treatment policy have any specific effect on PSA levels?

---

Copy For Citation

BAĞCIOĞLU M., Surcel C., Ozcan S., Mirvald C., Karagoz M. A., Karadag M. A., ...More

ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, vol.89, no.4, pp.282-286, 2017 (ESCI)

• Publication Type: Article / Article
• Volume: 89 Issue: 4
• Publication Date: 2017
• Doi Number: 10.4081/aiua.2017.4.282
• Journal Name: ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA
• Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
• Page Numbers: pp.282-286
• Hacettepe University Affiliated: Yes

Abstract

Objective: Androgen deprivation therapy (ADT) is commonly used as a first-line treatment for locally advanced and metastatic prostatic cancer (Pca). There is no consensus about which alternative treatment should be used after the failure of initial ADT. We aimed to investigate the effect of changes in treatment on PSA and testosterone levels.